Vaccines: past, present and future
PDF

Keywords

vaccination,
new technologies,
viral vectors.

How to Cite

BERDEU, I., SPATARU, D. and PARASCHIV, A. (2021) “Vaccines: past, present and future”, One Health & Risk Management , 2(2), pp. 27-35. Available at: https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/120 (Accessed: 20June2025).

Abstract

Introduction.  Vaccination is now entering the third century of its practice and it is the most important medical intervention that has ever been implemented. Due to vaccines, the incidence of infectious diseases, which have killed hundreds of millions throughout the history has been dramatically reduced and made a substantial contribution to life expectancy. Recently, new technologies have emerged in the development of vaccines that are being implemented in the control of the COVID-19 pandemic. The successful immunoprophylaxis and the better understanding of the immune response mechanisms suggest that vaccination would also help in curing cancer and chronic diseases in the nearest future.

Material and methods. There were analyzed 43 scientific articles on both vaccination and its future potential. 

Results. On 8 May 1980, the World Health Organization certified that smallpox had been eradicated globally. For the first time in history, the humankind defeated a disease. It was certainly the greatest medical achievement of the twentieth century. Recently, however, new technologies have emerged in the development of vaccines, based on mRNA, viral vectors and other technologies.

Conclusions. Vaccines are the most important medical achievement ever made with a great impact in eradicating and controlling emerging and re-emerging infectious diseases.

PDF

|Views: 487| |PDF Downloads: 412|


PDF

Downloads

Download data is not yet available.

ANNOUNCEMENT

Starting from July 1, 2025, the article processing fee will be 20 EUR (or the equivalent in MDL at the official exchange rate of the National Bank of Moldova). The publication fee for an accepted article will be 150 EUR (or the equivalent in MDL).

Details here:

Processing Fee
A processing fee of 20 EUR (or the equivalent in MDL) will be charged for articles accepted for scientific review by the editorial committee of the One Health and Risk Management journal.
Note: This fee will only be charged if your article has been technically reviewed and accepted.

Publication Fee
Starting from 01.07.2025, a fee of 150 EUR (or the equivalent in MDL) will be charged for articles accepted for publication.
Additionally, authors will bear the cost of English language editing/translation services if the manuscript requires intervention. The fee is 5 EUR (or the equivalent in MDL) per page edited/translated.
The total cost for English editing/translation services will be communicated by the Editorial Board after the manuscript is accepted for publication.

Payment Details:
Payments should be made in MDL to the bank account opened in the name of the Biosafety and Biosecurity Association of the Republic of Moldova.
The invoice will be issued by the end of the month in which the payment was made.

Organization: Biosafety and Biosecurity Association of the Republic of Moldova
Address: 5C A. Cozmescu Street
Fiscal Code: 1017620004120
Bank Code (SWIFT): AGRNMD2X451
IBAN: MD34AG000000022513622370